TWi Pharmaceuticals Overview
- Year Founded
-
2002
- Status
-
Private
- Employees
-
215
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
4
TWi Pharmaceuticals General Information
Description
Manufacturer of generic drugs intended to specialize development and commercialization of niche generic drugs. The company is engaged in the research and development, contract manufacturing and contract research including advanced scientific research, process development, patent analysis, regulatory compliance, and market and competition analysis, enabling its customers to avail the drug for combating disease and leading a healthier life.
Contact Information
Website
www.twipharma.comCorporate Office
- 3F, Number 41, Lane 221
- Gangqian Road
- Taipei City, Nei Hu 114
- Taiwan
Corporate Office
- 3F, Number 41, Lane 221
- Gangqian Road
- Taipei City, Nei Hu 114
- Taiwan
TWi Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TWi Pharmaceuticals Comparisons
Industry
Financing
Details
TWi Pharmaceuticals Competitors (34)
One of TWi Pharmaceuticals’s 34 competitors is Nymox Pharmaceutical, a Corporation company based in Saint Laurent, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nymox Pharmaceutical | Corporation | Saint Laurent, Canada | ||||
| Hoechst Pakistan | Corporate Backed or Acquired | Karachi, Pakistan | ||||
| Cipla | Corporation | Mumbai, India | ||||
| Genzyme Ireland | Corporation | Kilmeaden, Ireland | ||||
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy |
TWi Pharmaceuticals Patents
TWi Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2021512096-A | Topical formulation containing tofacitinib | Active | 31-Jan-2018 | ||
| US-12161748-B2 | Topical formulations comprising tofacitinib | Active | 31-Jan-2018 | ||
| US-20210212931-A1 | Topical formulations comprising tofacitinib | Active | 31-Jan-2018 | ||
| WO-2019152232-A1 | Topical formulations comprising tofacitinib | Inactive | 31-Jan-2018 | ||
| US-20150209292-A1 | Controlled release formulations and preparation method thereof | Inactive | 27-Jan-2014 | A61K31/4458 |
TWi Pharmaceuticals Signals
TWi Pharmaceuticals Investments & Acquisitions (4)
TWi Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Sevelamer ANDA. The deal was made on 01-Oct-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sevelamer ANDA | 01-Oct-2018 | Corporate Asset Purchase | Buildings and Property | ||
| Visum Pharmaceutical | 01-Jan-2015 | Corporate | Drug Discovery | ||
| Visum Pharmaceutical | 26-Sep-2014 | Merger/Acquisition | Drug Discovery | ||
| Visum Pharmaceutical | 10-Apr-2014 | Secondary Transaction - Private | Drug Discovery |
TWi Pharmaceuticals Exits (3)
TWi Pharmaceuticals’s most recent exit was on 01-Jan-2015 from Visum Pharmaceutical. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Visum Pharmaceutical | 01-Jan-2015 | Completed |
|
||
| Visum Pharmaceutical | 26-Sep-2014 | Completed |
|
||
| Visum Pharmaceutical | 10-Apr-2014 | Secondary Transaction - Private | Completed |
TWi Pharmaceuticals FAQs
-
When was TWi Pharmaceuticals founded?
TWi Pharmaceuticals was founded in 2002.
-
Where is TWi Pharmaceuticals headquartered?
TWi Pharmaceuticals is headquartered in Taipei City, Taiwan.
-
What is the size of TWi Pharmaceuticals?
TWi Pharmaceuticals has 215 total employees.
-
What industry is TWi Pharmaceuticals in?
TWi Pharmaceuticals’s primary industry is Drug Discovery.
-
Is TWi Pharmaceuticals a private or public company?
TWi Pharmaceuticals is a Private company.
-
What is TWi Pharmaceuticals’s current revenue?
The current revenue for TWi Pharmaceuticals is .
-
How much funding has TWi Pharmaceuticals raised over time?
TWi Pharmaceuticals has raised $111M.
-
Who are TWi Pharmaceuticals’s competitors?
Nymox Pharmaceutical, Hoechst Pakistan, Cipla, Genzyme Ireland, and Chiesi Farmaceutici are some of the 34 competitors of TWi Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process